NASDAQ:ATRA
Atara Biotherapeutics Stock News
$0.546
-0.0197 (-3.48%)
At Close: May 09, 2024
Canaccord Genuity Believes Regeneron (REGN) Still Has Room to Grow
10:08am, Tuesday, 28'th Apr 2020
In a report released yesterday, John Newman from Canaccord Genuity maintained a Buy rating on Regeneron (REGN), with a price target of $575.00. The
Contrasting Atara Biotherapeutics (NASDAQ:ATRA) & Acorda Therapeutics (NASDAQ:ACOR)
06:58am, Tuesday, 28'th Apr 2020
Atara Biotherapeutics (NASDAQ:ATRA) and Acorda Therapeutics (NASDAQ:ACOR) are both small-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the streng
7 Disruptive Biotech Stocks to Buy for 2025
02:56pm, Monday, 27'th Apr 2020
RBC Capital has peered into its crystal ball to reveal some of the market's most exciting biotech stocks. Here are seven that stand out.
2 Top Biotech Stocks Under $10
11:56am, Monday, 27'th Apr 2020
Amarin and Atara Biotherapeutics could both be diamonds in the rough.
William Blair Remains a Buy on Aileron Therapeutics (ALRN)
04:06pm, Friday, 24'th Apr 2020
William Blair analyst Matt Phipps maintained a Buy rating on Aileron Therapeutics (ALRN) on April 22. The company's shares closed last Friday at $0.53.
William Blair Remains a Buy on Aileron Therapeutics (ALRN)
04:06pm, Friday, 24'th Apr 2020
William Blair analyst
Matt Phipps
maintained a
Buy
rating on Aileron Therapeutics (
ALRN
–
Research Report
) on April 22. The company’s shares closed last Friday at $0.53.
According to
TipRanks.co
William Blair Remains a Buy on Incyte (INCY)
04:06pm, Friday, 24'th Apr 2020
In a report issued on April 20, Matt Phipps from William Blair maintained a Buy rating on Incyte (INCY). The company's shares closed last Friday at
William Blair Remains a Buy on Incyte (INCY)
04:06pm, Friday, 24'th Apr 2020
In a report issued on April 20, Matt Phipps from William Blair maintained a Buy rating on Incyte (INCY –
Analysts' Opinions Are Mixed on These Healthcare Stocks: Biogen (BIIB) and Zogenix (ZGNX)
04:06pm, Friday, 24'th Apr 2020
Analysts have been eager to weigh in on the Healthcare sector with new ratings on Biogen (BIIB) and Zogenix (ZGNX). Biogen (BIIB) In a report issued on
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Biogen (NASDAQ: BIIB) and Zogenix (NASDAQ: ZGNX)
04:06pm, Friday, 24'th Apr 2020
Analysts have been eager to weigh in on the Healthcare sector with new ratings on Biogen (
BIIB
–
Research Report
) and Zogenix (
ZGNX
–
Research Report
).
Biogen (BIIB)
In a report issued on Apri
Gilead Sciences (GILD) Receives a Buy from Mizuho Securities
06:07pm, Thursday, 23'rd Apr 2020
Mizuho Securities analyst Salim Syed maintained a Buy rating on Gilead Sciences (GILD) today and set a price target of $81.00. The company's shares closed
Gilead Sciences (GILD) Receives a Buy from Mizuho Securities
06:07pm, Thursday, 23'rd Apr 2020
Mizuho Securities analyst Salim Syed maintained a Buy rating on Gilead Sciences (GILD – Research Report) today and set a
Two shops cut views on Biogen as hopes for Alzheimer's med fade
11:13am, Thursday, 23'rd Apr 2020
Athersys (NASDAQ:ATHX) initiated with an Outperform rating and a $14 (528% upside) price target at SMBC Nikko.Livongo Health (NASDAQ:LVGO) initiated with a Buy rating and a $46 (22% upside) price targ
Atara Biotherapeutics upgraded to Buy on valuation at Citi ATRA
10:46am, Thursday, 23'rd Apr 2020
Atara Biotherapeutics upgraded to Buy on valuation at Citi Citi ATRA
Analysts Offer Insights on Healthcare Companies: Tactile Systems Technology (TCMD) and Aileron Therapeutics (ALRN)
10:05am, Thursday, 23'rd Apr 2020
There's a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Tactile Systems Technology (TCMD) and Aileron Therapeutics
